Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    " January 17, 2007":" February 16, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 17, 2007":" February 16, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring
Conditions: Acquired Immunodeficiency Syndrome;   Resistance
Intervention:
2 Completed Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
Condition: Acquired ImmunoDeficiency Syndrome (AIDS)
Intervention: Biological: HIV vaccine 732461
3 Completed Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
4 Completed Long Term Treatment Interruptions
Conditions: HIV Infections;   AIDS
Interventions: Other: STI;   Drug: stable HAART
5 Unknown  Assessment of Asymptomatic Heart Disease in Children With HIV
Condition: HIV Infections
Intervention: Procedure: echocardiography and blood test
6 Completed Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
Conditions: HIV Infections;   Substance Abuse;   Sexually Transmitted Diseases
Interventions: Behavioral: EDGE counseling, no maintenance;   Behavioral: EDGE counseling, plus maintenance;   Behavioral: Attention control
7 Completed Male Circumcision for HIV Prevention in Rakai, Uganda
Conditions: HIV Infections;   Herpesvirus 2, Human;   Syphilis;   Genital Diseases, Male
Intervention: Procedure: Adult male circumcision
8 Recruiting Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
Condition: HIV Infections
Intervention:
9 Completed Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults
Condition: HIV Infections
Interventions: Biological: EP-1233;   Biological: MVA-mBN32
10 Completed Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial
Condition: HIV Infections
Intervention: Behavioral: Nutritional
11 Active, not recruiting Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men
Conditions: Anus Neoplasms;   HIV Infections
Intervention: Procedure: Argon Plasma Coagulation
12 Unknown  Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
Conditions: HIV Infections;   Tuberculous Meningitis
Intervention: Drug: Combivir and efavirenz
13 Completed Pharmacogenetics of Antiretroviral Drugs
Condition: HIV Infections
Intervention:
14 Unknown  SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
Conditions: HIV Infections;   Lipodystrophy
Interventions: Drug: atazanavir (Reyataz);   Drug: ritonavir (Norvir)
15 Terminated Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.
Conditions: HIV Infections;   Lymphoma, Non-Hodgkin
Intervention: Procedure: autologous peripheral blood cell transplantation
16 Completed Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV
Condition: HIV Infections
Interventions: Drug: zidovudine;   Drug: amdoxovir;   Procedure: pharmacokinetic sampling
17 Completed Effects of Anti-HIV Therapy on Nervous System Function
Condition: HIV Infections
Intervention:
18 Terminated Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
19 Terminated Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddl/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: AZT/3TC/ LPV/r (zidovudine/lamivudine/ lopinavir-ritonavir);   Drug: - ABC/ddI or TDF/NVP or EFV (abacavir/didanosine or tenofovir/nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
20 Completed Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
Condition: HIV Infections
Interventions: Drug: Placebo;   Drug: Aprepitant

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years